Elucid vs Philips Imaging AI

Elucid is a service for coronary CT programs that bills each plaque analysis, and PlaqueIQ has 510(k) decisions from September 2024 and September 2026. Philips AI comes with its MR, CT and ultrasound systems on enterprise and OEM terms. Philips reported FDA clearance of SmartSpeed Precise, a dual-AI MR reconstruction for 1.5T and 3.0T dStream systems, in July 2025, though no K-number appears on the FDA AI list. The release body calls it available while its footnote says not yet CE marked and not available for sale. Precise Image, the CT reconstruction, has a 2022 510(k) decision (K210760), and a cardiac CT service has AV Cardiac CT, which carries a March 2026 decision on the FDA AI list. The sharpest Philips buyer is an echo lab, which gets DiA's LVivo (K243862, March 2025) for automated cardiac measurements.